The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

COPD 2024

Journal: Non Nocere. New Therapeutic Journal. 2024;(3): 80‑85

Read: 1355 times

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

COPD 2024. Non Nocere. New Therapeutic Journal. 2024;(3):80‑85. (In Russ.)

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

We publish the main theses of the main topic (chronic obstructive pulmonary disease) of the symposium "Cardiorespiratory comorbidity - therapeutic strategies in the conditions of forced polypragmasy", held within the framework of the XVIII National Congress of Therapists (with the support of AstraZeneca).

Close metadata

References:

  1. Smolonska J, Wijmenga C, Postma DS, Boezen HM. Meta-analyses on suspected chronic obstructive pulmonary disease genes: a summary of 20 years’ research. Am J Respir Crit Care Med. 2009 Oct 1;180(7):618-631.  https://doi.org/10.1164/rccm.200905-0722OC
  2. Chuchalin A, Khaltaev N, Antonov N, et al. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. Int J Chron Obstruct Pulmon Dis. 2014;9(1):963-974.  https://doi.org/10.2147/COPD.S67283
  3. Russian Respiratory Society. Draft clinical recommendations "Chronic obstructive pulmonary disease" [Electronic resource]. Date of reference: 04.03.2023. https://spulmo.ru/upload/kr/HOBL_2023_draft.pdf
  4. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 [Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023]. https://www.goldcopd.org/.Accessed:24January2023
  5. Giezeman M, Sundh J, Athlin Å. et al. Comorbid Heart Disease in Patients with COPD is Associated with Increased Hospitalization and Mortality – A 15-Year Follow-Up. Int J Chron Obstruct Pulmon Dis. 2023 Jan 9;18:11-21.  https://doi.org/10.2147/COPD.S378979
  6. Skajaa N, Laugesen K, Horváth-Puhó E, Sørensen HT. Comorbidities and mortality among patients with chronic obstructive pulmonary disease. BMJ Open Respir Res. 2023 Oct;10(1):e001798. https://doi.org/10.1136/bmjresp2023-001798.PMID:37797964
  7. Kunisaki K, M., Dransfield M. T., Anderson J. A., et al. Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial. Am J Respir Crit Care Med. 2018 Jul 1;198(1):51-57.  https://doi.org/10.1164/rccm.201711-2239OC
  8. Chen W, Thomas J, Sadatsafavi M, FitzGerald JM. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med. 2015 Aug;3(8):631-639.  https://doi.org/10.1016/S2213-2600(15)00241-6
  9. Miller J., Edwards L. D., Agustí A., et al. Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med. 2013 Sep;107(9):1376-1384. https://doi.org/10.1016/j.rmed.2013.05.001
  10. Donaldson GC, Hurst JR, Smith CJ, Hubbard RB, Wedzicha JA. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest. 2010 May;137(5):1091-1097. https://doi.org/10.1378/chest.09-2029
  11. Celli BR, Fabbri LM, Aaron SD, et al. An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal. Am J Respir Crit Care Med. 2021 Dec 1;204(11):1251-1258. https://doi.org/10.1164/rccm.202108-1819PP
  12. Whittaker H, Rubino A, Müllerová H., et al. Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study. Int J Chron Obstruct Pulmon Dis. 2022 Mar 3;17:427-437.  https://doi.org/10.2147/COPD.S346591
  13. van der Molen T, Cazzola M. Beyond lung function in COPD management: effectiveness of LABA/LAMA combination therapy on patient-centred outcomes. Prim Care Respir J. 2012 Mar;21(1):101-108.  https://doi.org/10.4104/pcrj.2011.00102
  14. Mahler DA, Decramer M, D’Urzo A, et al. Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: the BLAZE study. Eur Respir J. 2014 Jun;43(6):1599-1609. https://doi.org/10.1183/09031936.00124013
  15. Stoller JK, Panos RJ, Krachman S, Doherty DE, Make B; Long-term Oxygen Treatment Trial Research Group. Oxygen therapy for patients with COPD: current evidence and the long-term oxygen treatment trial. Chest. 2010 Jul;138(1):179-187.  https://doi.org/10.1378/chest.09-2555
  16. Avdeev S.N., Leshchenko I.V., Aisanov Z.R. New concept and algorithm for the management of patients with chronic obstructive pulmonary disease. Pulmonologiya. 2023;33(5):587-594. (In Russ.) https://doi.org/10.18093/0869-0189-2023-33-5-587-594
  17. Singh D, Agusti A, Martinez FJ, et al. Blood Eosinophils and Chronic Obstructive Pulmonary Disease: A Global Initiative for Chronic Obstructive Lung Disease Science Committee 2022 Review. Am J Respir Crit Care Med. 2022 Jul 1;206(1):17-24.  https://doi.org/10.1164/rccm.202201-0209PP
  18. Calzetta L, Ritondo BL, de Marco P, Cazzola M, Rogliani P. Evaluating triple ICS/LABA/LAMA therapies for COPD patients: a network meta-analysis of ETHOS, KRONOS, IMPACT, and TRILOGY studies. Expert Rev Respir Med. 2021 Jan;15(1):143-152.  https://doi.org/10.1080/17476348.2020.1816830
  19. Cazzola M, Rogliani P, Laitano R, Calzetta L, Matera MG. Beyond Dual Bronchodilation – Triple Therapy, When and Why. Int J Chron Obstruct Pulmon Dis. 2022 Jan 14;17:165-180.  https://doi.org/10.2147/COPD.S345263
  20. Mannino D, Bogart M, Germain G, et al. Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation. Int J Chron Obstruct Pulmon Dis. 2022 Mar 5;17:491-504.  https://doi.org/10.2147/COPD.S337668
  21. Martinez FJ, Rabe KF, Ferguson GT, et al. Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study. Am J Respir Crit Care Med. 2021 Mar 1;203(5):553-564.  https://doi.org/10.1164/rccm.202006-2618OC
  22. Lipson DA, Crim C, Criner GJ, et al. Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2020 Jun 15;201(12):1508-1516. https://doi.org/10.1164/rccm.201911-2207OC
  23. Chapman KR, Hurst JR, Frent SM, et al. Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial. Am J Respir Crit Care Med. 2018 Aug 1;198(3):329-339.  https://doi.org/10.1164/rccm.201803-0405OC
  24. Austin MA, Wills KE, Blizzard L, Walters EH, Wood-Baker R. Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial. BMJ. 2010 Oct 18;341:c5462. https://doi.org/10.1136/bmj.c5462
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.